ODT
Odonate Therapeutics, Inc. Common Stock
Delisted
ODT was delisted on the 14th of January, 2022.
52 hedge funds and large institutions have $480M invested in Odonate Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7% less capital invested
Capital invested by funds: $516M → $480M (-$35.9M)
Holders
52
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$26.9M | |
| 2 | +$4.87M | |
| 3 | +$1.68M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$961K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$733K |
Top Sellers
| 1 | -$6.7M | |
| 2 | -$2.06M | |
| 3 | -$1.07M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$971K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$440K |